Sun Pharmaceutical Industries Ltd. – FDA 483, Dec 13, 2019
Sun Pharmaceutical Industries Ltd. in Halol, India, a sterile and non-sterile drug manufacturer, was cited for multiple significant deficiencies during an FDA inspection. The observations highlight systemic failures in quality control, data integrity, aseptic processing, and manufacturing controls, indicating a lack of robust procedures and oversight to ensure drug product quality and purity. These issues include inadequate investigations into out-of-specification results, manipulable environmental monitoring data, and deficient visual inspection and environmental monitoring procedures.
ID · a825efb7-9662-4b1f-a2ee-debd514ac897
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.